Listing 1636 Views LIDDS to apply for listing on Nasdaq Stockholm Main Market Malin Otmani December 29, 2020 A listing on Nasdaq Stockholm …
Pharma Business 2177 Views Positive news from LIDDS Malin Otmani May 19, 2020 LIDDS has received positive responses …
New Market 1384 Views LIDDS’s Nanozolid registered in the US Malin Otmani January 23, 2020 LIDDS has announced that the …
Clinical Trials 1964 Views LIDDS licensee prepares for phase III trial in China Malin Otmani November 8, 2019 LIDDS licensee Jiangxi Puheng Pharma …
Clinical Trials 1214 Views LIDDS adds Lithuanian clinics to phase I study Malin Otmani November 6, 2019 LIDDS has received approval from …
Clinical Trials 1341 Views LIDDS’s Liproca Depot open label extension study indicates PSA reduction for up to one year Malin Otmani October 23, 2019 Data from a voluntary open …
Clinical Trials 1614 Views Preliminary results from LIDDS’ Phase IIb trial Malin Otmani September 25, 2019 The company has announced preliminary …
Business article 1632 Views Mini-interview: Monica Wallter, CEO of LIDDS Malin Otmani August 26, 2019 The last few months have …
In a new job 2135 Views New Project Manager at LIDDS Malin Otmani June 18, 2019 Erwin Brenndörfer has joined LIDDS …
Intellectual Property 1798 Views LIDDS’ technology receives US patent Malin Otmani March 26, 2019 The United States Patent and …
Clinical Trials 1402 Views Final patient enrolled in LIDDS Phase IIb study Malin Otmani March 6, 2019 The last patient has been …
Pharma Business 2034 Views Mini-interview: Monica Wallter, CEO of LIDDS Malin Otmani March 5, 2019 The last few months have …
CDMO 1785 Views Recipharm and LIDDS establish industrial manufacturing capabilities Malin Otmani August 9, 2017 Recipharm and LIDDS have together …
Collaboration 1664 Views Recipharm, LIDDS Talk Collaboration Ellen R. Delisio May 11, 2015 Recipharm has begun negotiations with …
